Advertisement
Advertisement
U.S. markets open in 6 hours 3 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.81-0.05 (-0.85%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close5.86
Open5.84
Bid0.00 x 1300
Ask0.00 x 800
Day's Range5.77 - 5.91
52 Week Range2.88 - 6.60
Volume367,859
Avg. Volume832,621
Market Cap598.302M
Beta (5Y Monthly)1.35
PE Ratio (TTM)8.25
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
-4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CPRX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Catalyst Pharmaceuticals, Inc.
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    16 hours agoMorningstar
View more
Advertisement
Advertisement